Hereditary muscular dystrophy in chickens of the New Hampshire strain was treated with penicillamine from the 9th day after hatching to the 425th day. The adult maintenance dose for males was 50 mg/kg per day and for females, 13-65 mg/kg per day. In avian dystrophy, deterioration of the muscle fibers is evidenced in the 2nd mo by an inability of the birds to rise after falling on their backs and by a progressive rigidity of the wings. The drug delayed the onset of symptoms and partially alleviated the debilitating aspects of the disease. Penicillamine produced three major improvements: (a) better righting ability when birds were placed on their backs; (b) greater wing flexibility; (c) and suppression of plasma creatine phosphokinase activity. The results are statistically analyzed and discussed in relationship to Duchenne dystrophy. Normal birds were not affected by penicillamine as judged by these parameters. The rationale for using penicillamine, a sulfhydryl compound with reducing properties, was (a) to attempt to protect essential thiol enzymes in the anabolic and glycolytic pathways against inactivation and (b) to prevent collagen crosslinking and deposition in muscle. Although the precise mechanism of drug action has not been determined. the possible role of penicillamine in mitigating the symptoms of genetic dystrophy in man is under consideration. A BSTRACT Hereditary muscular dystrophy in chickens of the New Hampshire strain was treated with penicillamine from the 9th day after hatching to the 425th day. The adult maintenance dose for males was 50 mg/kg per day and for females, 13-65 mg/kg per day. In avian dystrophy, deterioration of the muscle fibers is evidenced in the 2nd mo by an inability of the birds to rise after falling on their backs and by a progressive rigidity of the wings. The drug delayed the onset of symptoms and partially alleviated the debilitating aspects of the disease. Penicillamine produced three major improvements: (a) better righting ability when birds were placed on their backs; (b) greater wing flexibility; (c) and suppression of plasma creatine phosphokinase activity. The results are statistically analyzed and discussed in relationship to Duchenne dystrophy. Normal birds were not affected by penicillamine as judged by these parameters.
INTRODUCTION
This paper reports the results of our five-yr study on penicillamine treatment of hereditary muscular dystrophy in chickens. Genetic muscular dystrophy in the chicken may be considered as a model for inherited dystrophic diseases in humans (2) . In avian dystrophy there is progressive destruction of muscle fibers with necrosis, phagocytosis, and replacement of muscle with adipose and collagenous connective tissue. During the process there is an elevation of serum levels of muscle enzymes, such as creatine phosphokinase (CPK),1 aldolase, and serum glutamic oxaloacetic transaminase. The onset of symptoms in dystrophic chickens occurs in the 2nd mo after hatching. Chickens are unable to right after falling on their backs, and their wings become excessively stiff and eventually cannot be elevated beyond a horizontal plane. Penicillamine treatment partially alleviated the symptoms of the avian disease by improving the righting ability, producing greater flexibility of the wings, and suppressing plasma CPK levels. The relationship of these findings to human dystrophies and therapy will be considered in the Discussion.
The rationale behind penicillamine treatment was twofold: (a) to alter the intracellular redox status, thereby preventing oxidation of critical sulfhydryl groups of proteins; and (b) to decrease the formation of crosslinked, insoluble collagen in muscle. Penicillamine was selected as a suitable drug for a program with this rationale because it is relatively stable to auto-oxidation and metabolic degradation (3) . Moreover, penicillamine blocks collagen cross-linking by inhibiting the formation of Schiff's base intermediates and by cleaving inter- (4, 5) . Further studies are in progress to determine the mechanism of drug action.
METHODS
Chickens and maintenance. Dystrophic eggs and chickens were obtained as a gift from Dr. Louis Pierro, Department of Animal Genetics University of Connecticut at Storrs. Dystrophic chickens were of am/am mutation, originally seen in New Hampshire chickens and crossed with normal Leghorn stock (2) . Normal white Leghorn chickens were purchased from Smith Blanton Co., Nashville, Tenn. The birds were maintained on Purina Startena (Ralston Purina Co., St. Louis, Mo.). When an attempt was made to switch the dystrophic flock to Eggena or Layena, the new diet produced a deleterious effect on the general health of the birds. Water was supplied in plastic troughs to avoid excessive metal intake and the possible removal of free penicillamine in the body by formation of a chelated complex.
Grouiping of chickens. Young chicks were matched in pairs according to sex, body weight, and general health.
The paired chickens were separated into untreated and penicillamine-treated groups. Detailed data are reported for two separate studies: exp. A is a double-blind study on normal and dystrophic chickens, followed for 105 days; exp. B is a long-term experiment with a larger group of dystrophic chickens under treatment for 425 days.
Penicillamine treatment. Penicillamine (D-p, p dimethyl cysteine) was obtained from Merck Sharp & Dohme (Division of Merck & Co., Inc., Rahway, N. J.) as Cuprimine capsules. 32 capsules (250 mg/capsule) were opened and the powder was suspended in 40 ml of water. The suspension was heated in a water bath between 40 and 50'C for 15 min and the capsule filler was removed by filtration. The final penicillamine solution, 200 mg/ml as assayed by 5,5'-dithiobis-(2-nitobenzoic acid) titration (6) , was stored at -20'C for no longer than 2 mo. The capsules of penicillamine were used rather than the pure compound so that this work would be comparable to any future clinical experiments.
Starting on the 9th day after hatching, chicks were fed penicillamine or water daily through a tuberculin syringe without a needle. After 1 mo, a Schwarz/Mann automatic biopette was employed (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.). The feeding process had to be done slowly to prevent spitting, choking, or flooding of the lungs. In the first 3 or 4 mo, the dosage of penicillamine was determined by body weight and the general health of the birds. For chickens with diarrhea, vomiting, lethargy, or sudden weight loss, the dose of penicillamine was decreased. Average daily dosages are recorded in Figs. 1 
RESULTS

Experiment A
Design of exp. A. Eggs from normal and dystrophic chickens were hatched in our laboratory. The birds were randomly separated into four groups: untreated normals, penicillamine-treated normals, untreated dystrophics, and penicillamine-treated dystrophies. Since penicillamine has a very strong odor and cannot be disguised, a modified double-blind study was designed. Birds were administered either penicillamine or a water placebo by one investigator, who regulated the dose of the drug as described in Methods. The righting tests and wing apposition measurements were made independently by two other investigators who had no knowledge of the grouping of the chickens. This double-blind experiment insured that the measurements were objective and unbiased.
During the experiment five birds died. Two treated males (one normal and one dystrophic) died as a result of improper administration of penicillamine and flooding of the lungs. Two untreated birds (a normal female and a dystrophic male) died on the 45th day due to excessive anesthesia during muscle biopsy. Another bird died of unknown cause (a normal, treated female), and autopsy showed all organs were normal.
Body weight. Penicillamine treatment initially reduced the growth rate of both normal and dystrophic chickens. On the 105th day, the body weights of treated, d!strophic hens and roosters were approximately 15% lower than their untreated counterparts (Fig. 1 ever, exp. B (Fig. 4) showed that the weights of treated and untreated females were equal in the 4th mo, and the weights of males in the 5th mo. Normal males had essentially the same average body weight as the dystrophic males for 105 days. This was also true for the normal and dystrophic females. During growth, penicillamine treatment suppressed the weight of the normal and dystrophic chickens by approximately the same percentages.
Righting. After about 2 or 3 wk, untreated, dystrophic birds began to lose their ability to right (Fig. 2) preliminary experiments tolerated doses as high as 65 mg/kg per day.
Body weight. 10 days after hatching, the average body weight in all subgroups was about 53 g (Fig. 4) . Up to 50 days of age, the penicillamine-treated group, both male and female, had a 10-20% lower body weight. By 160 days, penicillamine-fed males and untreated males had the same average body weight and remained equal thereafter. At about 120 days, penicillamine-fed females became equal in weight to the untreated females, and by 180 days were 10% heavier.
Righting. After 30 days, untreated birds began to lose the ability to right (Fig. 5) . At two mo, untreated males had an average of only 0.4 successful trials (10%). Penicillamine-treated males showed a much slower decline and were able to right successfully on the average more than three times (80%). By 150 days, the number of successful righting trials for treated males plateaued at 2.0 or 50%. Approximately the same value was observed for untreated females. However, penicillamine-treated females had an almost perfect score throughout the entire 280 days and could unusual recovery of righting ability by untreated females was noted as peculiar to this particular group of birds. Roosters, both untreated and treated, never showed signs of recovery during this 3-mo period.
Testing and treatment were continued until day 425, and the righting values remained constant. In a detailed analysis from the 50th through the 210th day, 91% of the trials showed statistically significant improvement for the treated hens and 54% of the tests for treated roosters. From 50 through 80 days, the roosters showed statistically better righting on each trial day.
Wing apposition. During the 1st mo the distance between the raised wings was zero in all chickens (Fig. 6) . After 70 days, the subgroups began to show distinct differences, and by 200 days separated into three categories: (a) untreated males showed the greatest rigidity with an average of 4.9 inches between the wings; (b) penicillamine-fed males and untreated females had an average distance of 2.0-2.5 inches between the wings; (c) and the wings of penicillamine-fed females remained very flexible with an average distance less than 0.5 inches during the entire period. From the 40th to the 280th day, penicillamine treatment produced significant improvement on 97% of the test days with females and 75% of the test FIGURE 7 Plasma CPK levels in exp. B. CPK analyses were performed as described in the text. On any given day, each point is the average CPK value for five dystrophic chickens.
days with males as analyzed by Student's t test. Wing distances remained constant from day 280 to 425. CPK levels. For the plasma CPK analysis onl aily given day, five males and five females were randomly selected from the untreated and penicillamine-treated groups. The first analyses of the males oln the 43rd (lay showed low values of about 1,500 IU/liter (Fig. 7) . The CPK of untreated males rose to 17,600 on the 95th day and reached a maximum of 21,300 on 127th day. Penicillamine treatment suppressed these values to approximately half, 8,700 on the 95th day and 10,400 on the 127th day. There was also a lower plasma CPK level in the penicillamine-treated males subsequently on days 207 and 303. Farrell et al. have observed considerable variation in the time of CPK peaking and decline in individual chickens (7) . The unexpected drop in CPK value for the untreated male on the 165th day may reflct this type of variability. In a separate experiment, another group of untreated roosters had an average CPK value on the 150th day of 18,000, well above the treated level. Penicillamine treatment reduced the variability in both males and females, as indicated by the smaller standard error of the mean during the peak of CPK activity (Fig. 7) .
From the earliest analyses on days 43 and 76, untreated females had substantially higher CPK activities than the treated females. The peak of 14,000 IU/liter on the 95th day was lowered by penicillamine treatment to 5, 200 . By the 127th day the CPK activities for both untreated and treated females were essentially identical and remained so until the 280th day. According to Student's t test, the means were significantly different during the CPK peak at the 95th day for both hens and roosters. In normal chickens, the CPK levels are essentially constant for the first 170 days (7). DISCUSSION Therapeutic evaluation. Penicilliamine improved the dystrophic chickens as evidenced by righting ability and wing flexibility. The improved righting was not related to body weight but correlated with greater flexibility of the wings, as indicated in Figs. 2, 3 , 5, and 6. Comparison of individual chickens in any given category also confirmed this finding. However, in the terminal stages, some birds were so weak that they could not turn over despite very flexible wings.
Since the rigidity of the wings may be analogous to the contractures of human dystrophies, the effect of penicillamine on flexibility may be of clinical interest. Prevention of contractures in dystrophic patients might facilitate arm or hand movments and also prolong the period of walking.
Another observation of potential clinical interest was that earlier administration of penicillamine produced (8) . The catalytic site of glyceraldehyde-3-phosphate dehydrogenase has an exceptionally reactive sulfhydryl group required for high energy phosphate production (9, 10) . A number of other glycolytic enzymes, including CPK, also require sulfhydryl groups for maximal activity (11) . Penicillamine in vivo could protect these enzymes, either by disulfide interchange or by chelation with divalent metal ions that cause oxidation of sulfhydryl groups. In dystrophic chickens, the white muscle fibers depend primarily on the glycolytic pathway for ATP and are more severely affected than red muscle fibers (2) . These facts, however, are not sufficient to confirm the importance of sulfhydryl enzymes in the mechanism of drug action.
The effects of penicillamine on joint flexibility may be related to its action on collagen. This drug blocks the formation of new insoluble collagen, inhibits crosslinking, and degrades a certain fraction of recently synthesized insoluble collagen (4, 5) . These properties may alleviate tendon rigidity and infiltration of muscle by collagen. The greater improvement in flexibility associated with the earlier treatment of the chicks may also be explained by the work of Nimni et al. (5) , who found that the amount of degradation of preformed collagen in penicillamine-treated rats was greater in younger animals. The collagen extracted from younger rats was also more readily solubilized by penicillamine in vitro.
The suppression of plasma CPK by penicillamine may reflect a beneficial effect in preventing membrane damage and enzyme "leakage". Protein sulfhydryl groups and structural lipids are thought to be necessary for regulated permeability and integrity of membranes (12) (13) (14) . Metal (8) . Penicillamine, like vitamin E or cysteine, could also act as a chain breaker to decompose free radicals and peroxides of unsaturated fatty acids that lead to disruption of muscle membranes (15) and lysosomes (13, 16, 17) .
Currently the neural hypothesis of the etiology of muscular dystrophy is receiving considerable attention.
In this regard, sulfhydryl groups in the proteins of synaptic membranes may be important in neurotransmitter release as it relates to myopathies. Thiol-oxidizing agents, such as diamide, increase the number of disulfide bonds in the membrane proteins of the end-plate with concurrent release of acetylcholine (18, 19) . Excess acetylcholine has been shown to induce a myopathy in rat muscle with histochemical characteristics similar to Duchenne dystrophy (20) . The effect of diamide can be counteracted by reducing compounds, such as glutathione (18, 19) . Studies are currently underway to investigate further the mechanisms of therapeutic action of penicillamine in dystrophic chickens.
